Tests ozone therapy for pain in women with endometriosis
Tests ozone therapy as an add-on treatment for women with endometriosis.
Plain-language title generated from the registry record
Registry title: Ozone Therapy for Women With Endometriosis
Key facts
- Where
- Curitiba, BrazilSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 45 years old?
Source: NCT07035522, who can take part
Where in Brazil
- Clínica Fernanda Ferraz - Fisioterapia Integrativa LTDACuritiba, BrazilNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidade Federal do Paraná
- Trial code
- NCT07035522
- Record updated
- 25 June 2025
- Original description
To evaluate the action of ozone therapy as an adjuvant treatment in patients with endometriosis. Secondary Objective: To evaluate the efficacy of ozone therapy for pelvic analgesia in women with endometriosis; To compare the imaging diagnostic techniques of transvaginal ultrasound with infrared thermography in the pre-treatment (before), fourth, seventh and post-treatment (10th session) periods; To evaluate the application of the consolidated questionnaire (EHP-30) in the changes in the quality of life of the participants immediately after the intervention.Read full original descriptionShow less
Evaluation of the Effects of Ozone Therapy on Endometriosis
To evaluate the action of ozone therapy as an adjuvant treatment in patients with endometriosis. Secondary Objective: To evaluate the efficacy of ozone therapy for pelvic analgesia in women with endometriosis; To compare the imaging diagnostic techniques of transvaginal ultrasound with infrared thermography in the pre-treatment (before), fourth, seventh and post-treatment (10th session) periods; To evaluate the application of the consolidated questionnaire (EHP-30) in the changes in the quality of life of the participants immediately after the intervention.
Inclusion: Women with a clinical diagnosis of endometriosis (ultrasonography / transvaginal exam); 25-45 years old.
Exclusion: Endometrial surgery history; HIV and hepatitis positive; Cancer; Pregnancy; G6PD positive; Addicted; Anticoagulant sensitive.